Reviva Pharmaceuticals Holdings (RVPH) Enterprise Value (2021 - 2026)
Reviva Pharmaceuticals Holdings' Enterprise Value came in at -$11.63 million for Q2 2026, compared with $8.63 million a year earlier.
Powered by 
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Enterprise Value (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Reviva Pharmaceuticals Holdings reported Enterprise Value of -$61.44 million; for FY2025, it was $5.8 million, down 87.5% from FY2024.
- Enterprise Value carries a five-year compound annual growth rate of -20.3% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $46.52 million in FY2024 (-61.4%), $120.41 million in FY2023 (+76.1%), $68.38 million in FY2022 (+28.1%) and $53.39 million in FY2021.
- The five-year range for quarterly Enterprise Value is -$17.06 million (Q1 2026) to $121.58 million (Q2 2023).
- The fastest year-over-year change in Enterprise Value over five years came in Q3 2023 (growth of 928.8%), and the weakest in Q2 2022 (a decline of 96.9%).
- Business Quant data shows RVPH's Enterprise Value at -$17.06 million (Q1 2026), $5.8 million (Q4 2025) and $13.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Reviva Pharmaceuticals Holdings | 4.46 Mn | -82.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -11.30 Mn |
| Jun 30, 2026 | -11.63 Mn |
| Mar 31, 2026 | -17.06 Mn |
| Dec 31, 2025 | -7.42 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | -395,148.01 |
| Mar 31, 2025 | 35.44 Mn |
| Dec 31, 2024 | 34.32 Mn |
| Sep 30, 2024 | 38.40 Mn |
| Jun 30, 2024 | 27.06 Mn |
| Mar 31, 2024 | 93.56 Mn |
| Dec 31, 2023 | 120.41 Mn |
| Sep 30, 2023 | 95.80 Mn |
| Jun 30, 2023 | 121.58 Mn |
| Mar 31, 2023 | 74.44 Mn |
| Dec 31, 2022 | 68.38 Mn |
| Sep 30, 2022 | 9.31 Mn |
| Jun 30, 2022 | 893,176.00 |
| Mar 31, 2022 | 13.81 Mn |
| Dec 31, 2021 | 12.02 Mn |
API Access
Reviva Pharmaceuticals Holdings Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=RVPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "RVPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=RVPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();